Detalhe da pesquisa
1.
Esketamine inhaled as dry powder: Pharmacokinetic, pharmacodynamic and safety assessment in a preclinical study.
Pulm Pharmacol Ther
; 73-74: 102127, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35429651
2.
CPL207280, a Novel G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1-Specific Agonist, Shows a Favorable Safety Profile and Exerts Antidiabetic Effects in Type 2 Diabetic Animals.
Mol Pharmacol
; 100(4): 335-347, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34349026
3.
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II-Benzimidazole Derivatives.
Pharmaceuticals (Basel)
; 15(8)2022 Jul 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36015075
4.
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I-Indole Derivatives.
Pharmaceuticals (Basel)
; 15(8)2022 Jul 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36015098
5.
Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey.
PLoS One
; 16(9): e0257477, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34555055
6.
Discovery and development of CPL207280 as new GPR40/FFA1 agonist.
Eur J Med Chem
; 226: 113810, 2021 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34537444
7.
Unexpected role of O-2 "protecting" groups of glycosyl donors in mediating regioselective glycosidation.
J Am Chem Soc
; 124(13): 3198-9, 2002 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-11916390